Author:
Bahnassy Abeer A,Zekri Abdel Rahman N,Saleh Maha,Lotayef Mohammad,Moneir Manar,Shawki Osama
Abstract
Abstract
Background
Human papillomavirus (HPV) 16 and 18 are associated with cervical carcinogenesis through an interaction between HPV oncogenic proteins and cell cycle regulatory genes. However, the exact pathogenetic mechanisms are not determined yet.
Methods
We investigated 43 invasive squamous cell carcinoma (ISCC), 38 CIN III, 11 CINII and 18 CINI for cyclin D1, cyclin E, CDK4, p53, mdm-2, p21
waf
, p27, p16
INK 4A
, Rb and Ki-67 aberrations using immunohistochemistry and molecular techniques. Twenty samples of normal cervical tissues (NCT) were taken as a control.
Results
There was a significant increase in the expression of Ki-67, cyclin E, CDK4, p16
INK 4A
, Rb (p= 0.003, 0.001, 0.001, 0.01) and a significant decrease in p27
KIP 1from NCT to ISCC (p = 0.003). Increased cyclin D1, p21
waf
, p53, mdm-2 expression, homozygous deletion (HZD) and promoter methylation (PM) of the Rb were detected in CINIII and ISCC only. On univariate analysis; tumor size, differentiation, lymph node status, FIGO stage, Ki- 67, cyclin D1, p53 and p27
KIP 1are significantly associated with reduced overall survival (OS) while on multivariate analysis; only FIGO stage, Ki-67, cyclin D1, p53 and p27
KIP 1were significant.
Conclusion
1) Aberrations involving p27
KIP 1, cyclin E, CDK4, p16
INK 4A
are considered early events in HPV 16 and 18-associated cervical carcinoma, whereas cyclin D1 and p53 pathway abnormalities are considered late events. 2) Immunohistochemical tests for p16
INK 4A
and cyclin E, could help in early diagnosis of cervical carcinoma. 3) Only FIGO stage p53, cyclin D1, p27
KIP 1and Ki-67 are independent prognostic factors that might help in predicting outcome of cervical cancer patients.
Publisher
Springer Science and Business Media LLC
Subject
Histology,Pathology and Forensic Medicine
Reference30 articles.
1. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P, Von Knebel Doeberitz M: Detection of high risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer res. 1999, 59: 6132-9616.
2. Clarke B, Chetty R: Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2001, 82 (2): 238-246. 10.1006/gyno.2001.6306.
3. Howley PM, Scheffner M, Munger K: Oncoproteins encoded by the cancer-associated papillomavirus target the products of retinoblastoma and p53 tumor suppressor genes. Quant Biol. 1991, 56: 149-155.
4. Masumoto T, Fuji T, Ishikawa M, Saito M, Iwata T, Fukuchi T, Susumu N, Mukai M, Kubushiro K, Tsukazaki K, Nozawa S: p16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol. 2003, 34: 778-783. 10.1016/S0046-8177(03)00284-3.
5. Spitokovsky D, Aengeneyndt F, Braspenning J, Doeberitz VK: P53-independent growth regulation of cervical cancer cells by the papillomvirus E6 oncogene. Ocogene. 1996, 13: 1027-1035.